Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    21293309 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Attention & Memory Impairments in Menopausal Women
Conditions: Symptomatic Menopause;   Cognitive Impairments
Intervention: Drug: Lisdexamfetamine
2 Completed LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women
Conditions: Menopause;   Brain Activity;   Cognition
Intervention: Drug: Lisdexamfetamine

Indicates status has not been verified in more than two years